Patrolling monocytes control tumor metastasis to the lung

Science. 2015 Nov 20;350(6263):985-90. doi: 10.1126/science.aac9407. Epub 2015 Oct 22.

Abstract

The immune system plays an important role in regulating tumor growth and metastasis. Classical monocytes promote tumorigenesis and cancer metastasis, but how nonclassical "patrolling" monocytes (PMo) interact with tumors is unknown. Here we show that PMo are enriched in the microvasculature of the lung and reduce tumor metastasis to lung in multiple mouse metastatic tumor models. Nr4a1-deficient mice, which specifically lack PMo, showed increased lung metastasis in vivo. Transfer of Nr4a1-proficient PMo into Nr4a1-deficient mice prevented tumor invasion in the lung. PMo established early interactions with metastasizing tumor cells, scavenged tumor material from the lung vasculature, and promoted natural killer cell recruitment and activation. Thus, PMo contribute to cancer immunosurveillance and may be targets for cancer immunotherapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Immunologic Surveillance / immunology*
  • Immunotherapy / methods
  • Killer Cells, Natural / immunology
  • Lung Neoplasms / immunology*
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / therapy
  • Mice
  • Mice, Mutant Strains
  • Monocytes / immunology*
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasms, Experimental / immunology
  • Neoplasms, Experimental / secondary
  • Nuclear Receptor Subfamily 4, Group A, Member 1 / genetics

Substances

  • Nr4a1 protein, mouse
  • Nuclear Receptor Subfamily 4, Group A, Member 1